Invesco
PGNX

Invesco’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Invesco’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-459,930
Closed -$1.75M – 3729
2020
Q1 		$1.75M Sell
459,930
-20,251
-4% -$87.2K ﹤0.01% 2471
2019
Q4 		$2.44M Buy
480,181
+34,608
+8% +$183K ﹤0.01% 2555
2019
Q3 		$2.25M Sell
445,573
-73,456
-14% -$366K ﹤0.01% 2570
2019
Q2 		$3.2M Sell
519,029
-211,725
-29% -$1.02M ﹤0.01% 2438
2019
Q1 		$3.39M Sell
730,754
-125,995
-15% -$570K ﹤0.01% 2269
2018
Q4 		$3.6M Sell
856,749
-295,218
-26% -$1.5M ﹤0.01% 2136
2018
Q3 		$7.22M Buy
1,151,967
+580,966
+102% +$4.46M ﹤0.01% 1931
2018
Q2 		$4.59M Buy
571,001
+276,282
+94% +$2.11M ﹤0.01% 2189
2018
Q1 		$2.2M Buy
294,719
+105,101
+55% +$699K ﹤0.01% 2519
2017
Q4 		$1.13M Buy
189,618
+18,027
+11% +$110K ﹤0.01% 2948
2017
Q3 		$1.26M Sell
171,591
-526,274
-75% -$3.34M ﹤0.01% 2876
2017
Q2 		$4.74M Sell
697,865
-726,149
-51% -$5.36M ﹤0.01% 1996
2017
Q1 		$13.4M Buy
1,424,014
+1,028,388
+260% +$10.3M ﹤0.01% 1379
2016
Q4 		$3.42M Buy
+395,626
New +$2.92M ﹤0.01% 2222
2016
Q3 		– Sell
-100,059
Closed -$422K – 3698
2016
Q2 		$422K Sell
100,059
-196,837
-66% -$950K ﹤0.01% 3308
2016
Q1 		$1.29M Sell
296,896
-40,200
-12% -$179K ﹤0.01% 2753
2015
Q4 		$2.07M Buy
337,096
+3,831
+1% +$25.1K ﹤0.01% 2505
2015
Q3 		$1.91M Buy
333,265
+332,555
+46,839% +$2.55M ﹤0.01% 2538
2015
Q2 		$5K Buy
+710
New +$4.3K ﹤0.01% 4247
2014
Q2 		– Sell
-29,948
Closed -$122K – 4103
2014
Q1 		$122K Buy
+29,948
New +$153K ﹤0.01% 3902

Other funds holding PGNX

ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $49.2B AUM 29.3% 1-Year Est. Return
Daiwa Securities Group
Daiwa Securities Group Tokyo, Japan $34.8B AUM 20.7% 1-Year Est. Return

Invesco's PGNX Position: Q2 2020 in Review

Invesco sold out of Progenics Pharmaceuticals Inc (PGNX) in Q2 2020, closing a stake of 459,930 shares — an estimated $1.75M sold.

Invesco first reported a position in PGNX in Q1 2014 and held it in 20 quarters. The position peaked at $13.4M in Q1 2017. 3 funds tracked by Wall St. Rank hold PGNX as of Q2 2020.

  • Invesco reported no remaining Progenics Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
  • Invesco sold 459,930 Progenics Pharmaceuticals Inc shares in Q2 2020, an estimated $1.75M.
  • Invesco first reported a position in Progenics Pharmaceuticals Inc in Q1 2014 and held it in 20 quarters.
  • Invesco's Progenics Pharmaceuticals Inc position peaked at $13.4M in Q1 2017.
  • 3 funds tracked by Wall St. Rank held Progenics Pharmaceuticals Inc as of Q2 2020.

Based on Invesco's 13F filing for Q2 2020, filed 14 Aug 2020.